Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
GSK Launches Open Innovation Contest
by Lisa M. Jarvis
May 27, 2013
| A version of this story appeared in
Volume 91, Issue 21
In its latest bid to enhance relationships with academic scientists, GlaxoSmithKline has kicked off a competition intended to speed the translation of basic research into drug candidates. Winners of the Discovery Fast Track contest will have to come up with a novel therapeutic hypothesis plus target, assay protocols, and reagents. They will then be teamed with researchers in GSK’s Discovery Partnerships with Academia unit, who will develop a high-throughput assay to test the target against GSK’s compound library. Registration for the contest closes on July 19.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X